Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug:204:136-137.
doi: 10.1016/j.thromres.2021.06.005. Epub 2021 Jun 16.

When to use anticoagulation in COVID-19

Matthew Moll  1 , Jean M Connors  2
Affiliations
Comment

When to use anticoagulation in COVID-19

Matthew Moll et al. Thromb Res. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: M. Moll has no conflicts of interest. J.M. Connors reports personal fees for scientific Ad Boards and Consulting: Abbott, Anthos, Alnylam, Bristol-Myers Squibb, Portola, Takeda. Research funding to the institution from CSL Behring.

Comment on

References

    1. Connors J.M., Levy J.H. COVID-19 and its implications for thrombosis and anticoagulation. Blood. Jun 4 2020;135(23):2033–2040. doi: 10.1182/blood.2020006000. (PMID: 32339221; PMCID: PMC7273827) - DOI - PMC - PubMed
    1. Nopp S., Moik F., Jilma B., Pabinger I., Ay C. Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Res. Pract. Thromb. Haemost. Sep 25 2020;4(7):1178–1191. doi: 10.1002/rth2.12439. (Epub ahead of print. PMID: 33043231; PMCID: PMC7537137) - DOI - PMC - PubMed
    1. Moll M., Zon R.L., Sylvester K.W., Chen E.C., Cheng V., Connell N.T., Fredenburgh L.E., Baron R.M., Cho M.H., Woolley A.E., Connors J.M. VTE in ICU patients with COVID-19. Chest. Nov 2020;158(5):2130–2135. doi: 10.1016/j.chest.2020.07.031. (Epub 2020 Jul 22. PMID: 32710891; PMCID: PMC7674987) - DOI - PMC - PubMed
    1. Moll M., Zon R.L., Sylvester K.W., Rimsans J., Chen E.C., Ghosh A.J., Abston E., Kim A., Rutherford H., Mitre X., Hakim A., Connell N.T., Battinelli E., Fredenburgh L.E., Baron R.M., Hobbs B.D., Cho M.H., Mittleman M.A., Woolley A.E., Connors J.M. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: a propensity score-matched analysis. Thromb. Res. Apr 19 2021;203:57–60. doi: 10.1016/j.thromres.2021.04.009. (Epub ahead of print. PMID: 33940309; PMCID: PMC8053596) - DOI - PMC - PubMed
    1. Lim W., Meade M., Lauzier F., Zarychanski R., Mehta S., Lamontagne F., Dodek P., McIntyre L., Hall R., Heels-Ansdell D., Fowler R., Pai M., Guyatt G., Crowther M.A., Warkentin T.E., Devereaux P.J., Walter S.D., Muscedere J., Herridge M., Turgeon A.F., Geerts W., Finfer S., Jacka M., Berwanger O., Ostermann M., Qushmaq I., Friedrich J.O., Cook D.J., PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients. Crit. Care Med. Feb 2015;43(2):401–410. doi: 10.1097/CCM.0000000000000713. (PMID: 25474533) - DOI - PubMed